To memory, i recently saw on channel 7 about a product called Aldara (which i believe is an Australian product) and has recently been released in the US. I believe it's also due for release in OZ later this yr. What i'm unsure of is whether this will be a competitor of PEP as a topical formulation for basal cell carcinoma. PEP still has a long way to go, and i'm somewhat surprised that it's SP has held up so well considering it's still in the test tube stage. Obviously, the Allergan deal has had a lot to do with this! It's certainly a company to look out for in '04 with promising results from it's in vitro studies and its human studies in its most natural form.
PEP Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held